v3.25.4

OTHER NON-OPERATING INCOME, NET (Details) - USD ($)	12 Months Ended
OTHER NON-OPERATING INCOME, NET (Details) - USD ($)	Dec. 31, 2025	Dec. 31, 2024
OTHER NON-OPERATING INCOME, NET [Abstract]
Research and Development tax incentive Accrued Previous Fiscal Year	$ 200,000	$ 300,000
Research and Development tax incentive Accrued	0	800,000
Holdback Amount Receivable	$ 0	$ 1,376,000
Le Maitre Vascular Incorporation [Member]
OTHER NON-OPERATING INCOME, NET [Abstract]
Percentage of Holdback Receivable Recognized		67.00%
Holdback Amount Receivable		$ 2,000,000

Total holdback receivable related to distribution sales agreement.

+ References

No definition available.

+ Details

Name:	avr_HoldbackAmountReceivable
Namespace Prefix:	avr_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Percentage of holdback receivable recognized during the period.

+ References

No definition available.

+ Details

Name:	avr_PercentageOfHoldbackReceivableRecognized
Namespace Prefix:	avr_
Data Type:	dtr:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount of research and development tax incentive recognized or (reversed) during the period, pertaining to current year.

+ References

No definition available.

+ Details

Name:	avr_ResearchAndDevelopmentTaxIncentiveAccrued
Namespace Prefix:	avr_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Amount of research and development tax incentive recognized or (reversed) during the period relating to previous year .

+ References

No definition available.

+ Details

Name:	avr_ResearchAndDevelopmentTaxIncentiveAccruedPreviousFiscalYear
Namespace Prefix:	avr_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 730
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483041/730-20-50-1

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 730
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483041/730-20-50-1

+ Details

Name:	us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	us-gaap_RelatedPartyTransactionAxis=avr_LeMaitreVascularIncorporationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Anteris Technologies Global Corp. 10-K